DL

Deval Lashkari

Director Board Of Directors at EditCo Bio

Deval Lashkari is a highly experienced professional in the biotechnology and investment sectors, currently serving as a Senior Partner at Telegraph Hill Partners since 2001. In addition to this role, Deval Lashkari holds multiple directorships on the boards of various companies, including EditCo Bio, n6 Tec, Panome Bio, Mosaic Biosciences, Excellos, Cell Microsystems, Nimble Therapeutics, Dynex Technologies, and Carterra. Deval Lashkari earned a PhD in Genetics from Stanford University School of Medicine and a Bachelor of Arts in Genetics with Highest Honors from the University of California, Berkeley.

Location

San Francisco, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


EditCo Bio

Whatever your edit, we can make it easier with optimized, multi-guide CRISPR kits and made-to-order edited cells. We're dedicated to building a novel research toolkit to make genome engineering simpler and more efficient. EditCo's CRISPR expertise and highly automated manufacturing allows us to engineer a wide variety of cell lines with the speed, consistency, and functionality than can redefine research. Leave CRISPR to us–you focus on discoveries.


Employees

51-200

Links